S.Amdt. 3611Senate115th Congress (2017-2019)
S.Amdt. 3611
Sponsored by
Sen. Richard J. Durbin (D-IL)
Submitted July 25, 2018
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
July 25, 2018
Text
Submitted
SA 3611. Mr. DURBIN (for himself and Mr. Grassley) submitted an amendment intended to be proposed by him to the bill H.R. 6147, making appropriations for the Department of the Interior, environment, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place in title VII of division C, insert the following: Sec. __. The authority of the Secretary of Health and Human Services to regulate direct-to-consumer advertising of prescription drugs, pursuant to the authorities under sections 502(n) and 503C of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352(n), 353c), shall include the authority to require such advertising to include an appropriate [[Page S5390]] disclosure of pricing information with respect to such drugs. The Secretary of Health and Human Services shall issue regulations to implement this section. A drug that is advertised to consumers without the information required by this section or its implementing regulations shall be deemed to be misbranded under section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352). ______